Coronary artery disease: from bench to bedside Predictive value of neutrophil to lymphocyte ratio in long-term outcomes of left main and/or three-vessel disease in patients with acute myocardial infarction in

Abstract:Background: Patients with acute coronary syndrome due to left main and/or three-vessel disease (LM/3VD) are at the highest risk of adverse cardiovascular events. Neutrophil to lymphocyte ratio (NLR) has been proposed as a marker of cardiovascular risk,but the prognostic value of NLR in patients with LM/3VD who underwent percutaneous coronary intervention (PCI) is not clearly defined. We sought to evaluate the independent predictive value of NLR for LM/3VD in AMI patients. Methods: Patients (n=806) admitted with LM/3VD in AMI and who underwent PCI between January 2013 and December 2013 were followed up for 2 years. NLR was calculated as the ratio of neutrophil to lymphocyte based on the labo- ratory data on admission. The primary end point was all-cause death. The secondary end point was long-term major adverse cardiovascular and cerebrovas- cular events (MACCE). We used Cox regression models to examine the relation between NLR and clinical outcomes. Results: In of the and of Methods: Freshly isolated cells from MI patients were treated with recombinant human cytokines (TNF-a, IL-1b, IL-6, IL-7 and IL-15) and the number, activation, function and proliferation of CD28null T cells were analysed. Results: We found that pro-inflammatory cytokines TNF-a, IL-1b and IL-6 did not have any effect on CD28null T cell number. Strikingly, homeostatic cytokines IL- 7 and IL-15 triggered expansion of CD28null T cells from MI patients, which was mediated by cell proliferation. Moreover, we demonstrate for the first time that IL-7 and IL-15 activate CD28null T cells and increase their cytotoxic function. Conclusions: We showed that IL-7 and IL-15 and not pro-inflammatory cytokines are the main drivers of CD28null T cell expansion in MI patients. Our novel findings suggest that anti-inflammatory drugs targeting TNF-a, IL-1 and IL-6 may fail to control CD28null T cell expansion in MI patients and that therapeutic strategies targeting alternative cytokines (IL-7, IL-15) may be beneficial. Soluble Methods: We measured plasma suPAR by ELISA in 62 patients with non- obstructive coronary artery disease (CAD, fractional flow reserve > 0.75) who underwent radiofrequency IVUS (VH-IVUS). The association between suPAR lev- els and VH-IVUS-defined plaque burden (plaque area/vessel area × 100) and composition (necrotic core, dense calcium, and fibrous and fibrofatty tissue) was characterized using univariable and multivariable analyses. Multivariable analyses adjusted for age, sex, eGFR, diabetes, and hypertension. Results: Median age was 57 (IQR 48, 63) years, 51% men, 23% diabetic, and 71% hypertensive. Median suPAR level was 2.81 (IQR 1.99, 3.44) ng/mL and median plaque burden was 38 (IQR 27, 48)%. In univariable analyses, suPAR levels correlated with percent necrotic core (r=+0.30, p=0.02) and percent dense calcium (r=+0.27, 0.04) among plaque components. These associations remained significant in multivariable analyses adjusting for the aforementioned factors ( β =+0.24 [0.01, 1.04], p=0.047 and β =+0.23 [0.03, 1.07], p=0.038, re-spectively). There was no correlation between suPAR levels and plaque burden. secondary to increased plaque vulnerability (high risk plaque) in those with elevated suPAR levels. Background: MAIR-II (Myeloid-Associated Immunoglobulin-Like Receptor II) is expressed on myeloid cells and is involved in Toll-like receptor-4 (TLR4)-mediated inflammatory monocyte migration from the blood to sites of infection as part of the host response in polymicrobial peritonitis. Following myocardial infarction (MI), monocytes are known to be recruited to infarcted myocardium. However, the un- derlying mechanism is not yet completely understood. Purpose: To investigate the role of MAIR-II in MI pathophysiology. Methods and results: In flow cytometric analysis, MAIR-II+ myeloid cells were abundant from post-MI days 3 to 5 in infarcted hearts induced by permanent lig- ation of the left coronary artery. To address the role of MAIR-II in myeloid cell function in vivo, effects of MAIR-II deficiency were investigated. In echocardio- graphy, MAIR-II knockout (KO) mice had thicker left ventricle posterior walls and higher ejection fractions compared to wild-type (WT) mice. This indicates that MAIR-II deficiency leads to favorable post-MI remodelling. After further investi-gation, we found that MAIR-II KO hearts had less macrophage influx and more neutrophil | Background: Statins can contribute to the stabilization of coronary plaques. Purpose: The aim of the present study was to assess the effect of early statin therapy on fibrous cap thickness in coronary plaques of acute coronary syndrome (ACS) patients by using optical coherence tomography (OCT).

Medicine